![Robert Klupacs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Klupacs
Direktor/Vorstandsmitglied bei
EPIMINDER LIMITED
Vermögen: 160 607 $ am 31.05.2026
Profil
Robert Klupacs was the founder of ES Cell International Pte Ltd., founded in 2000, where the title held was Chief Executive Officer from 2010 to 2011.
Current jobs include Chief Executive Officer at The Bionics Institute of Australia since 2017, Chairman at Syngene Ltd. since 2012, Non-Executive Director at Epiminder Ltd. since 2017, and Member at The Australian Institute for Performing Arts.
Former jobs include Chairman at Bio-Gene Technology Ltd. from 2020 to 2023, Executive Director at Opthea Ltd. in 2013, Director-Intellectual Property & Member at Amrad Pharmaceuticals Pty Ltd. from 1988 to 1999, Member at Pharmaceuticals Industry Council, and Chief Operating Officer at Monash Institute of Medical Research in 2001.
Education includes undergraduate studies at Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EPIMINDER LTD. 0,26 % | 15.05.2026 | 565.121 ( 0,26 % ) | 160 607 $ | 31.05.2026 |
Aktive Positionen von Robert Klupacs
| Unternehmen | Position | Beginn |
|---|---|---|
| EPIMINDER LIMITED | Direktor/Vorstandsmitglied | 25.09.2017 |
The Australian Institute for Performing Arts | Corporate Officer/Principal | 18.02.2011 |
Syngene Ltd.
 Syngene Ltd. Pharmaceuticals: MajorHealth Technology Holds licences for use of synthetic genetic molecules and their application as gene diagnostics or as antisense pharmaceuticals | Vorsitzender | - |
Bionics Institute
 Bionics Institute Miscellaneous Commercial ServicesCommercial Services Engages in medical research | Vorstandsvorsitzender | 18.05.2017 |
Ehemalige bekannte Positionen von Robert Klupacs
| Unternehmen | Position | Ende |
|---|---|---|
| BIO-GENE TECHNOLOGY LIMITED | Vorstandsvorsitzender | - |
| OPTHEA | Vorstandsvorsitzender | 03.12.2013 |
Monash Institute of Medical Research | Geschäftsführer | 01.01.2001 |
Amrad Pharmaceuticals Pty Ltd.
 Amrad Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01.01.1999 |
Pharmaceuticals Industry Council
 Pharmaceuticals Industry Council Pharmaceuticals Industry Council was a non-profit organisation. The company has been forum for developing, evaluating and providing expert advice to government on issues affecting the Australian pharmaceuticals industry. It brought together senior executives from companies and peak bodies representing three industry sectors, including the research-based and generic medicines sectors and the biotechnology sector. The company was founded in 2006 and is headquartered in Deakin, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Robert Klupacs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Amrad Pharmaceuticals Pty Ltd.
Amrad Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syngene Ltd.
Syngene Ltd. Pharmaceuticals: MajorHealth Technology Holds licences for use of synthetic genetic molecules and their application as gene diagnostics or as antisense pharmaceuticals | Health Technology |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology Provides regenerative medical products | Health Technology |
Bionics Institute
Bionics Institute Miscellaneous Commercial ServicesCommercial Services Engages in medical research | Commercial Services |
Pharmaceuticals Industry Council
Pharmaceuticals Industry Council Pharmaceuticals Industry Council was a non-profit organisation. The company has been forum for developing, evaluating and providing expert advice to government on issues affecting the Australian pharmaceuticals industry. It brought together senior executives from companies and peak bodies representing three industry sectors, including the research-based and generic medicines sectors and the biotechnology sector. The company was founded in 2006 and is headquartered in Deakin, the United Kingdom. | |
The Australian Institute for Performing Arts | |
Monash Institute of Medical Research | |
Bio-Gene Technology Ltd.
 Bio-Gene Technology Ltd. Chemicals: AgriculturalProcess Industries Engages in developing and supplying insecticides for controlling insects | Process Industries |
Epi-Minder Pty Ltd.
 Epi-Minder Pty Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops EEG monitoring wearable processor | Electronic Technology |
Wählen Sie MarketScreener 
